Navigation Links
Watson to Acquire Arrow Group
Date:6/17/2009

manufacturing network, including facilities in Canada, Malta and Brazil, will further expand Watson's global supply chain."

Key Benefits of the Transaction Include:

  • Expanded Commercial Footprint: Arrow's global commercial footprint in many established and emerging countries allows Watson to introduce its generic and brand products into these markets. Arrow's manufacturing network will further expand Watson's global supply chain. Additionally, Arrow owns an extensive portfolio of product registrations in regions where it does not yet have a commercial presence. This will allow Watson to rapidly and efficiently expand its sales and marketing operations into these markets.
  • Strong Product Portfolio and Pipeline: Since 2000, Arrow has launched an extensive portfolio of products into more than 20 countries. This includes more than 50 molecules developed internally. In addition, Arrow expects approval of 40 new molecules over the next three years. Successful patent challenges and settlements will allow for significant U.S. generic product launches over the next three years, including exclusive U.S. rights to launch the authorized generic version of Lipitor(R) (atorvastatin) in November 2011.
  • Provides Foundation for Generic Biologics: Arrow owns approximately 36% of Eden Biodesign, a biopharmaceutical company that provides development and manufacturing services to early stage biotechnology companies. Watson believes Eden will provide the operational expertise and manufacturing capability to support its long term investment in generic biologics.
  • Efficient Execution and Integration: Arrow's global footprint and product portfolio has minimal overlap with Watson's and the Company anticipates that the integration of the two businesses will be very manageable. Arrow brings a global sales, legal and regulatory infrastructure to complement Watson'
    '/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Watson Files FDA Application for Generic Mucinex(R) D
2. Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB)
3. Watson-Marlow Releases Informative Video Featuring Showcased High Purity Pumps, Tubing and Fillers at Interphex 2009
4. Watson Pharmaceuticals Reports First Quarter 2009 Results; Raises 2009 Outlook
5. Watson Files FDA Applications for Generic Mucinex(R)
6. Watson to Host and Webcast Investment Community Meeting at American Urological Association Annual Meeting
7. Companies Continue To Add Wellness Programs, Watson Wyatt/National Business Group On Health Survey Finds
8. Mark G. Watson Named Executive Director of Radiological Society of North America
9. Watson Pharmaceuticals and Elan Settle Lawsuit Over Naproxen Sodium
10. Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results; Provides 2009 Outlook
11. Watson Acknowledges Federal Trade Commission Action Regarding AndroGel Patent Settlement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... of the antidepressant Lexapro appears to help prevent ... study finds. The condition is known ... people with this condition may not develop noticeable ... blood supply, according to researchers from Duke University ... the researchers found that people taking the antidepressant ...
(Date:5/22/2013)... By Dennis Thompson HealthDay Reporter , , TUESDAY, ... Americans isn,t improving much, with about six in 10 ... in unhealthy behaviors like smoking, heavy drinking or not ... Tuesday by the U.S. Centers for Disease Control and ... of the lifestyle choices that have led to soaring ...
(Date:5/22/2013)... May 22 (HealthDay News) -- Roughly four in 10 ... pulmonary disease (COPD) actually do not have the lung ... Faulty diagnoses were made based on an evaluation of ... standard" disease test known as spirometry, which shows how ... amount of air they can exhale and how long ...
(Date:5/22/2013)... Atlanta, GA (PRWEB) May 22, 2013 ... marketing agency, JD Media Surge, LLC, E-Dentists.com has ... subjects. The blog will feature numerous topics of ... on treatment options and dental health. , ... element of dental Internet marketing. In addition to ...
(Date:5/22/2013)... Macedon, NY (PRWEB) May 22, 2013 ... other lean manufacturing improvements use the new Do-Done StepTracker ... coordination. “We use the Do-Done board to display the ... Each of our production cells and departments is listed ... top. As we start a project, the squares are ...
Breaking Medicine News(10 mins):Health News:Antidepressants May Be Helpful for Some Heart Patients: Study 2Health News:Antidepressants May Be Helpful for Some Heart Patients: Study 3Health News:Americans Still Making Unhealthy Choices: CDC 2Health News:Americans Still Making Unhealthy Choices: CDC 3Health News:COPD May Be Over-Diagnosed Among Uninsured 2Health News:Dental SEO Blog Launched by E-Dentists.com in Partnership with JD Media Surge, LLC 2Health News:Project Managers Organize Manufacturing Projects and Training with the New Steptracker Project Status Magnetic Whiteboards 2
... N.J., July 9 Red wine (resveratrol) pills appear to be ... to lead the way for patients and consumers to learn more ... do so. , , (Photo: http://www.newscom.com/cgi-bin/prnh/20090709/LA44390 ) , ... of red wine pills, a local cardiology group says it will ...
... Today Americans United for Life (AUL) President & CEO Dr. ... members, urging them to ask Judge Sotomayor the "Top Ten" most ... the Court as the Senators prepare for her confirmation hearings to ... CEO Dr. Charmaine Yoest said, "It,s important for the American people ...
... As part of its Patient Voices series, ... is featuring the stories of people from across the country who ... Patient Voices seeks to give a glimpse into the life ... diverse as the disease itself, and include actress/model and Lupus Foundation ...
... 1 diabetes or having a preceding infection are associated with more ... 49 years old, according to a Finnish study. Furthermore, heart failure ... cancer malignancy with 16 times the risk of death in stroke ... group, said Jukka Putaala, M.D., who led the study. Risk of ...
... The President of the American Chemical Society, ... President Obama,s nomination of Francis Collins, M.D., Ph.D., to ... other time in recent memory has there been such a ... of science to deliver solutions to the grand challenges facing ...
... hits $42 million a year , THURSDAY, July 9 (HealthDay News) ... at least $42 million a year, a new study finds. , ... 100,000 young people annually, said Dr. Warren Lo, lead author of ... but there is growing concern about the cost of medical care ...
Cached Medicine News:Health News:Local Heart Doctors First in Nation to Announce Active Investigation of Red Wine (Resveratrol) Pills, Issue Consumer Precautions 2Health News:Local Heart Doctors First in Nation to Announce Active Investigation of Red Wine (Resveratrol) Pills, Issue Consumer Precautions 3Health News:Local Heart Doctors First in Nation to Announce Active Investigation of Red Wine (Resveratrol) Pills, Issue Consumer Precautions 4Health News:AUL President to Senate Judiciary Committee: Ask Top 10 Questions to Judge Sotomayor 2Health News:The New York Times Website Patient Voices Series Features People Affected by Lupus 2Health News:Stroke in Children Rare But Costly 2Health News:Stroke in Children Rare But Costly 3
(Date:5/22/2013)... 22, 2013 MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) ... about some recent company developments. As Medifirst continues to ... communication with shareholders. Integrating social media into its investor ... and will post updates on Twitter.  The Facebook homepage ... Says CEO Bruce J. ...
(Date:5/22/2013)... --  Life Line Screening  (LLS), a leading national ... of a unique partnership with MCM Solutions for ... a population health management organization. LLS will provide health ... important expanded services will help MCM and its clients ... cost of care when individuals are able to address ...
(Date:5/22/2013)... , May 22, 2013  Generex Biotechnology Corporation ... demonstrating the superiority of the AE37 breast cancer vaccine ... ( www.antigenexpress.com ). The presentations will be made at ... Oncology (ASCO) to be held in Chicago ... The presentation entitled " Booster inoculations of ...
Breaking Medicine Technology:Medifirst Solutions, Inc. Announces Update To Shareholders 2Life Line Screening and MCM Solutions for Better Health Announce New Partnership 2Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 2Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 3Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: